Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 04, 2021 10:48pm
80 Views
Post# 33653065

RE:RE:voucher cash, when is it coming? See latest NR ...

RE:RE:voucher cash, when is it coming? See latest NR ...

Liminal pays the plasma division bills until the voucher is sold. Liminal should be desperate to close deal but surprisingly they are not as they announce Fez lead indicators are not going to Phase 2 with money running out and thomvest not giving a bridge loan. I wonder why? Doesn't it make you think that something bad is happening with management and Thomvest?
 

Kedrion is happy to wait until end of 2021 to get things organized to take over.


captsecord wrote: Kedrion wants to close this deal asap so cant be too long.

tommyjones1 wrote:

...the Rare Pediatric Disease Priority Review Voucher ("PRV") by its subsidiary, Prometic Biotherapeutics Inc. ("PBT"), which would be payable to Liminal prior to closing the divestment of its remaining plasma-derived therapeutics business operated through PBT (the "Second Closing").

So anytime now...

-----------------------------------------------------------------------------------------------------------------

everybody on this board and the market manipulators want your shares... this stock wil ride high next days...

 

This is whats next: 100M$ cash influx (voucher) on a market cap of... +- 90M$ ... the sp will explode up. Thats why these jokers are here posting nonstop.


 


With this FDA ok, we can sell that riplazym voucher...market price is between 80M$-120M$ u.s., so lets say 100M$ u.s., we get 70%.... 70M$ u.s. + 17M$ u.s. we cashed already, around 100M$ can$ , lmnl will be able to execute big time and do more deals like this (sell or partner), we gat some in the oven already. Doyour dd. Dont listen to the clown$ operating on this board.  They are here for $$$... accumulation time....





<< Previous
Bullboard Posts
Next >>